Upregulation of these inflammatory mediators has been linked to the pathogenesis of autoimmune disorders, and plays a potential role in tumor progression and metastasis (see Figure 2) [33,34,35] as well as the pathogenesis of autoimmune neurological diseases (CCL20) [34]. This evidence concerns the gene CCL20 and autoimmune disorder of the nervous system.